Cognitive function in patients with malignant lymphoma undergoing chemotherapy -Relation to physical and mental function and treatment-related factors
Not Applicable
- Conditions
- malignant lymphoma
- Registration Number
- JPRN-UMIN000044892
- Lead Sponsor
- agasaki University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
When the attending physician deems it inappropriate Patients with psychiatric disorders Patients with serious cardiac, respiratory, hepatic or renal dysfunction Patients with malignant lymphoma with primary central nervous system or brain lesions Patients with a history of dementia Patients with a history of central nervous system disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Montreal Cognitive Assessment-japan
- Secondary Outcome Measures
Name Time Method Age, gender, Treatment period, PS, IADL, anxiety, fatigue, pain, grip strength, Timed Up and Go Test